Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (591-600 of 663) with videos related to

Pageof 67
Sort By:
Circulation|June 21, 2019
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular DiseaseClaire Welsh, Carlos A Celis-Morales, Rosemary Brown, et al.
International Journal of Cardiology|September 3, 2016
Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trialBiniyam G Demissei, Douwe Postmus, Licette C Y Liu, et al.
Circulation. Heart Failure|August 11, 2016
Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart FailureJozine M Ter Maaten, Kevin Damman, Jennifer S Hanberg, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 1, 2020
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fractionJozine M Ter Maaten, Pieter Martens, Kevin Damman, et al.
European Journal of Heart Failure|April 30, 2016
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHFAdriaan A Voors, Stefan D Anker, John G Cleland, et al.
Journal of the American College of Cardiology|October 21, 2017
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF SubanalysisAntoni Bayes-Genis, Julio Núñez, Faiez Zannad, et al.
International Journal of Cardiology|March 17, 2018
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failureJorge Rubio-Gracia, Biniyam G Demissei, Jozine M Ter Maaten, et al.
European Journal of Heart Failure|April 16, 2022
Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure)Candace D McNaughton, Alex McConnachie, John G Cleland, et al.
European Journal of Heart Failure|April 2, 2022
Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK BiobankTripti Rastogi, Frederick K Ho, Patrick Rossignol, et al.
International Journal of Cardiology|June 1, 2022
Heart failure with normal LVEF in BIOSTAT-CHFLukas Baumhove, Jasper Tromp, Sylwia Figarska, et al.
Pageof 67

Showing results (591-600 of 663) with videos related to

Sort By:
Pageof 67
Circulation|June 21, 2019
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular DiseaseClaire Welsh, Carlos A Celis-Morales, Rosemary Brown, et al.
International Journal of Cardiology|September 3, 2016
Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trialBiniyam G Demissei, Douwe Postmus, Licette C Y Liu, et al.
Circulation. Heart Failure|August 11, 2016
Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart FailureJozine M Ter Maaten, Kevin Damman, Jennifer S Hanberg, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 1, 2020
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fractionJozine M Ter Maaten, Pieter Martens, Kevin Damman, et al.
European Journal of Heart Failure|April 30, 2016
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHFAdriaan A Voors, Stefan D Anker, John G Cleland, et al.
Journal of the American College of Cardiology|October 21, 2017
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF SubanalysisAntoni Bayes-Genis, Julio Núñez, Faiez Zannad, et al.
International Journal of Cardiology|March 17, 2018
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failureJorge Rubio-Gracia, Biniyam G Demissei, Jozine M Ter Maaten, et al.
European Journal of Heart Failure|April 16, 2022
Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure)Candace D McNaughton, Alex McConnachie, John G Cleland, et al.
European Journal of Heart Failure|April 2, 2022
Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK BiobankTripti Rastogi, Frederick K Ho, Patrick Rossignol, et al.
International Journal of Cardiology|June 1, 2022
Heart failure with normal LVEF in BIOSTAT-CHFLukas Baumhove, Jasper Tromp, Sylwia Figarska, et al.
Pageof 67